UiPath Shares Down 19.2% as Healthcare AI Tools and WorkFusion Enhance Automation
Over the past month, UiPath shares slid 19.2% with a consensus EPS estimate unchanged at $0.25 for the quarter. The firm forecasts 9.7% sales growth this quarter and launched healthcare AI tools and integrated WorkFusion’s offerings to bolster its agentic automation lineup.
1. Recent Stock Movement
Over the past 30 days, UiPath stock declined 19.2%, underperforming the Internet software industry’s 9.8% drop and the S&P 500’s 0.6% gain, reflecting investor caution ahead of updates on growth drivers.
2. Earnings and Sales Estimates
Consensus estimates project EPS of $0.25 for the current quarter (–3.9% year-over-year) and sales of $464.9 million (+9.7% year-over-year), with annual revenue forecasts of $1.59 billion (+11.5%) and $1.74 billion (+9.4%).
3. Healthcare AI Tool Launch
On February 23, UiPath unveiled new AI-driven automation tools for healthcare providers and insurers designed to connect data silos, reduce administrative burdens, summarize medical records and speed authorizations, targeting revenue cycle efficiency.
4. WorkFusion Acquisition
UiPath completed the acquisition of WorkFusion to strengthen its agentic AI portfolio, integrating advanced intelligent automation capabilities to expand its product suite and address complex enterprise workflows.